Gennaro Musi

ORCID: 0000-0003-0833-9183
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Renal cell carcinoma treatment
  • Urologic and reproductive health conditions
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Radiotherapy Techniques
  • Genital Health and Disease
  • Testicular diseases and treatments
  • Renal and related cancers
  • Inflammatory Biomarkers in Disease Prognosis
  • Renal and Vascular Pathologies
  • Cancer, Lipids, and Metabolism
  • MRI in cancer diagnosis
  • Urinary Bladder and Prostate Research
  • Surgical Simulation and Training
  • Colorectal Cancer Screening and Detection
  • COVID-19 and healthcare impacts
  • Cancer Immunotherapy and Biomarkers
  • Epigenetics and DNA Methylation
  • Esophageal Cancer Research and Treatment
  • Hormonal and reproductive studies
  • Adrenal and Paraganglionic Tumors

European Institute of Oncology
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2018-2025

University of Milan
2006-2025

Ripamonti
2014-2024

Ospedale San Paolo
2024

Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
2024

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2022

University of Naples Federico II
2022

Ospedale Maggiore
2022

Vall d'Hebron Hospital Universitari
2018

No AccessJournal of UrologyAdult Urology1 Mar 2020Impact Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter StudyThis article is commented by the following:Editorial Comment Andrea Minervini, Riccardo Campi, Brian R. Lane, Ottavio De Cobelli, Francesco Sanguedolce, Georgios Hatzichristodoulou, Alessandro Antonelli, Sabrina Noyes, Mari, Oscar Rodriguez-Faba, Frank X. Keeley, Johan Langenhuijsen,...

10.1097/ju.0000000000000591 article EN The Journal of Urology 2019-10-14

Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does study add? The open simple prostatectomy (OSP) is ‘gold standard’ for high‐volume prostate adenomas. It shows very good functional results despite its invasiveness. Minimally invasive approaches, e.g. laparoscopy or holmium laser enucleation prostate, have been ‘tested’ but none proved a substitute OSP. robot‐assisted approach provides optimal easy to perform experienced robotic surgeons....

10.1111/j.1464-410x.2012.11192.x article EN BJU International 2012-05-18

Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) Cancer Antigen 3 (PCA3) proposed as new more biomarkers. We evaluated the ability of phi PCA3 identify cancer (PCa) at initial biopsy in men with total PSA range 2–10 ng/ml. The performance were 300 patients undergoing first biopsy. ROC curve analyses tested accuracy (AUC) predicting PCa. Decision (DCA) used compare clinical benefit two found that...

10.1371/journal.pone.0067687 article EN cc-by PLoS ONE 2013-07-04

To investigate the prognostic role of neutrophil percentage-to-albumin ratio (NPAR) in muscle-invasive bladder cancer (MIBC) patients treated with neoadjuvant chemotherapy (NAC) and radical cystectomy (RC).213 were included.Nonmetastatic, MIBC (cT2-T4aN0M0), at least three cycles NAC, undergone RC blood count within 30 days before NAC.Five-years overall survival (OS) NPAR >18 was 34.06% (95% CI: 18.3-50.5) 65.37% 52.4-75.6) <18. Five years cancer-specific (CSS) 42.9% 23.9-60.7) 74.5%...

10.2144/fsoa-2021-0008 article EN cc-by Future Science OA 2021-04-20

Over the years, five different Trifecta score definitions have been proposed to optimize framing of "success" in partial nephrectomy (PN) field. However, such classifications rely on metrics. The aim present study was explore how success rate robotic PN, as well its drivers, vary according currently available Trifecta.Data from consecutive patients with cT1-2N0M0 renal masses treated PN at 16 referral centers September 2014 March 2015 were prospectively collected. defined for each...

10.23736/s2724-6051.21.04601-2 article EN Minerva Urology and Nephrology 2022-03-01

Abstract Purpose In radioguided surgery (RGS), radiopharmaceuticals are used to generate preoperative roadmaps (e.g., PET/CT) and facilitate intraoperative tracing of tracer avid lesions. Within RGS, there is a push toward the use receptor-targeted radiopharmaceuticals, trend that also has align with surgical move minimal invasive robotic surgery. Building on our initial ex vivo evaluation, this study investigates clinical translation DROP-IN β probe in PSMA-guided prostate cancer Methods A...

10.1007/s00259-024-06653-6 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2024-02-20

Robot-assisted surgery is rapidly developing in the medical field, and integration of augmented reality shows potential to improve operation performance surgeons by providing more visual information. In this paper, we proposed a markerless framework enhance safety avoiding intra-operative bleeding, which high risk caused collision between surgical instruments delicate blood vessels (arteries or veins). Advanced stereo reconstruction segmentation networks are compared find best combination...

10.1016/j.neunet.2024.106469 article EN cc-by Neural Networks 2024-06-19
Coming Soon ...